Trial Profile
Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Metoprolol
- Indications Essential hypertension
- Focus Pharmacodynamics
- 12 Jul 2011 Planned end date changed from 1 Mar 2012 to 1 May 2010 as reported by ClinicalTrials.gov.
- 04 Jun 2010 Status changed from recruiting to discontinued.
- 02 Jun 2010 Actual patient number (1) added as reported by ClinicalTrials.gov.